ATH Price sensitive 24 Jul 2025, 10:08 AM

Peer-Reviewed Publication on Novel MRI Endpoint from bioMUSE

Alterity Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in